The effect of probiotic in HIV patients
- Conditions
- HIV.Unspecified human immunodeficiency virus [HIV] disease
- Registration Number
- IRCT2016092228308N1
- Lead Sponsor
- Vice chancellor for research Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Confirm HIV infection by Western blot analysis; lack of criteria for initiating treatment according to national HIV guideline; no use of probiotic supplements in the past 6 months ; have a consent to conduct research Exclusion criteria:On Highly Active Anti Retroviral Therapy (HAART) regimens; active addiction; opportunistic infection in the past; Liver or Kidney failure; inflammatory bowel disease and other well known Gastrointestinal pathology; active infection and fever; younger than 18 and older than 65 years; have a cancer, pregnancy and breastfeeding; being dependent on alcohol; a history of allergy or sensitivity to the probiotic or lactose intolerance; use of other supplement drugs, and multivitamins; Use of growth hormone, testosterone or anabolic agent during the last 6 months.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CD4. Timepoint: At baseline ,three months later, and after 6 months. Method of measurement: Based on the number per microliter by laboratory blood tests.
- Secondary Outcome Measures
Name Time Method CRP. Timepoint: At baseline ,three months later, and after 6 months. Method of measurement: Based on the number per microliter by laboratory blood tests.;Side effects. Timepoint: every 4 week after intervention. Method of measurement: Based on side effects checklist.